ZEB2 and breast cancer: Since miR-205 directly targets ZEB1 and ZEB2 in Madin Darby canine kidney cells [17], reduced expression of miR-205 could maintain breast cancer cells in the mesenchymal state through ZEB1/ZEB2 inhibition of E-cadherin (CDH1).